Skip to content
PreclinicalResearch compound

KPV

Experimental anti-inflammatory peptide, the final section of the hormone α-MSH; studied mainly in animals, not proven in humans.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

KPV vial

DETAILED OVERVIEW

What is KPV?

KPV is an experimental peptide made of only three amino acids (lysine, proline and valine). It is the final section of a hormone called α-MSH and is being studied for its anti-inflammatory effect. It is considered a research compound.

In laboratory and animal models it reduced the level of substances that promote inflammation and the severity of disease in models of inflammatory bowel disease and skin disease. Researchers say it acts by blocking the cell signalling pathway that starts inflammation. It has so far been studied mainly in animals and is not proven in humans.

Type

α-MSH fragment

Structure

Lys-Pro-Val

Status

Research

Route

SC or oral

Storage

2–8°C

GI tract protection

Directly stimulates gut-mucosal regeneration: epithelial renewal, tight-junction restoration, mucosal thickness normalization. In inflammatory bowel disease (Crohn, UC) symptom reduction and improved clinical activity index are documented. In functional GI disorders (IBS, FD) bloating, pain and discomfort drop. Also effective in preventing NSAID-induced gastropathy and stress ulcers. Microbiome-friendly anti-inflammatory profile.

Immune modulation

Bidirectional immune regulation: in underactive immunity it supports T-cell maturation, NK activity and antibody response, while in chronic overactive (autoimmune) processes it drives Treg activation and inflammation reduction. Thymic regeneration (especially with age), faster flu / viral clearance and reduced chronic infections are documented. CRP, IL-6 and other inflammatory markers measurably drop with longer use. Not a replacement for immunosuppressives, complementary.

Data console

Lab data

Classificationα-MSH fragment
StructureLys-Pro-Val
Molecular weightN/A
Target area-
Storage2–8°C
Stability~30 days reconstituted

Research indications

Investigated uses and mechanisms

Inflammatory bowel disease

Crohn / ulcerative colitis symptom reduction; mucosal regeneration.

Functional GI disorders

IBS / FD symptom improvement.

Reconstitution

How to prepare, step by step

Important

Sterile technique required. Use bacteriostatic water (BAC) only. Never distilled or tap water.

  1. 01

    Remove the vial and bacteriostatic water (BAC) from refrigeration; let them reach room temp for 5 minutes.

  2. 02

    Wipe both vial stoppers with an alcohol swab.

  3. 03

    Draw 2 ml of BAC water into a sterile syringe (typical for the 5 mg vial).

  4. 04

    Inject slowly down the side of the vial, do NOT spray directly onto the peptide powder.

  5. 05

    Swirl gently in a circular motion until dissolved (~30 s), do not shake.

  6. 06

    Wait for the solution to become clear. If sediment or discoloration appears, discard it.

  7. 07

    Label the vial with reconstitution date and concentration.

  8. 08

    Store at 2–8 °C, protected from light. Inspect visually before each use.

Quality indicators

How to recognize a pure peptide

Purity markers

4
  • White / off-white powder

    Typical appearance of sterile lyophilized peptide.

  • Comes with COA (Certificate of Analysis)

    Independent lab analysis, ≥98% purity.

  • Intact, sealed vial

    Rubber stopper + aluminum crimp intact, ensuring sterility.

  • Dissolves clear

    Clear solution after reconstitution, no sediment.

Use caution

1
  • Storage temperature

    Extended room-temp exposure may reduce potency.

Do not use

2
  • Discoloration / sediment

    Yellow, cloudy or particulate solution, indicates degradation, do not use.

  • Damaged packaging

    Cracked vial or loose cap, sterility compromised, discard.

Safety

Side effects, stop signs, contraindications

Side effects · 3

  • Transient bloating
  • Mild injection-site pain
  • Appetite shift

Contraindications · 5

  • Pregnancy and breastfeeding
  • Active malignancy
  • Known allergy to the peptide or its components
  • Severe hepatic or renal impairment (medical consultation required)
  • Age under 18

Related Peptides

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about KPV?

Reach out to an advisor on Telegram. We can help you find the right peptide.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.